ResMed Inc. (ASX: RMD)

ResMed Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Net Income	897.56	474.51	474.51	404.59	404.59
Depreciation & Amortization	197.56	191.52	181.37	150.8	150.8
Share-Based Compensation	71.14	65.26	63.93	57.56	52.07
Other Operating Activities	-472.96	5.44	82.45	-153.9	-148.41
Operating Cash Flow	693.3	736.72	802.26	459.05	459.05
Operating Cash Flow Growth	-5.89%	-8.17%	74.76%	0%	-9.10%
Capital Expenditures	-134	-116.83	-105.94	-77.34	-77.34
Acquisitions	-1,012.75	-39.07	-27.91	-951.38	-951.38
Change in Investments	-51.36	-41.01	-65.23	-55.61	-1,045.35
Other Investing Activities	38.27	38.44	19.22	8.63	998.36
Investing Cash Flow	-1,159.85	-158.46	-179.86	-1,075.71	-1,075.71
Dividends Paid	-258.28	-245.34	-226.71	-225.09	-211.71
Common Stock Issued	49.14	37.79	37.79	36.73	36.73
Share Repurchases	-30.63	90	-50.21	-22.84	-50.95
Other Financing Activities	601.38	-467.08	-625.92	746.17	704.68
Financing Cash Flow	422.87	-764.63	-764.63	580.64	580.64
Net Cash Flow	-45.82	-167.88	316.03	-41.57	-41.57
Free Cash Flow	559.3	619.89	696.32	381.71	381.71
Free Cash Flow Growth	-9.77%	-10.98%	82.42%	0%	-11.96%
Free Cash Flow Margin	13.24%	19.39%	23.55%	14.64%	14.64%
Free Cash Flow Per Share	0.38	0.42	0.48	0.26	0.26

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.